Traders Should Be Looking to Buy Into These Stocks On Any Weakness
Momentum indicators are an early warning sign of an impending rally.
Read Moreby Jeff Clark, Jeff Clark Trader | Oct 15, 2026
Momentum indicators are an early warning sign of an impending rally.
Read Moreby Anthony Summers, The Oxford Club | Oct 15, 2026
Its current cash flow suggests a minimal chance of a near-term cut, but its falling cash flow and past dividend cut are real marks against its record.
Read Moreby Benjamin Rains, Zacks | Oct 14, 2026
Now might be time for investors to consider buying the beaten-down name for long-term upside and near-term breakout potential.
Read Moreby Brett Owens, Contrarian Outlook | Oct 14, 2026
The best dividend deals are right now as Christmas (for dividend investors!) is set to arrive two months early.
Read Moreby Brett Eversole, DailyWealth.com | Oct 14, 2026
In short, this is a yellow light, not a red light…
Read Moreby Phil Lamanna, Daily Trade Alert | Oct 14, 2026
Here are today’s upgrades and downgrades: Lockheed Martin, Dell Technologies, HPE, Trane, Carrier Global, Glencore, Alcoa, Texas Roadhouse, Albertsons and more.
Read Moreby Michael Foster, Contrarian Outlook | Oct 13, 2026
It’s a ‘one-stop shop’ for US market access holding names like NVIDIA (NVDA) and Apple (AAPL), as well as smaller companies like Halozyme Therapeutics (HALO) and Moog (MOG.A).
Read Moreby James Brumley, The Motley Fool | Oct 13, 2026
While the retail industry as a whole may be running into a headwind driven by the growth of e-commerce, the top players in the business are doing just fine. Here are three names to consider.
Read Moreby Cody Alexander, Money Morning | Oct 13, 2026
Money will keep flowing to platforms that sit in the path of that traffic and turn scattered tools into one defense system.
Read Moreby Phil Lamanna, Daily Trade Alert | Oct 13, 2026
Here are today’s upgrades and downgrades: Adobe, AT&T, AstraZeneca, RTX, VF Corp., Linde, Prologis, Orion180 Insurance, Electra Therapeutics and more.
Read Moreby Jason Fieber, Dividends And Income | Oct 12, 2026
With a market-beating yield, high-single-digit dividend growth, more than 10 consecutive years of dividend increases, and the potential that shares are 10% undervalued, this looks like a great idea for long-term dividend growth investors.
Read Moreby Ethan Feller, Zacks | Oct 12, 2026
It offers a compelling combination of strong earnings growth, upward estimate revisions, attractive valuation and bullish price momentum.
Read More
